Regen Med. 2011 Nov;6(6 Suppl):109-12. doi: 10.2217/rme.11.73.
Regenerative Medicine talks to Bernard Siegel, Executive Director of the Genetics Policy Institute (GPI) and founder of the annual World Stem Cell Summit. Bernard Siegel, JD, is the Founder and full-time Executive Director of the nonprofit Genetics Policy Institute (GPI), based in Wellington, FL, USA. He is the creator and co-chair of the World Stem Cell Summit series of global conferences and Editor-in-Chief of the World Stem Cell Report, which he also founded. He traded his 30-year courtroom career to found GPI, which leads the global 'Pro-Cures Movement' and Stem Cell Action Coalition. As a recognized policy expert on to stem cell research, regenerative medicine and cloning, Mr Siegel works with the world's leading stem cell researchers and advocates. Mr Siegel serves on the board of directors of the Coalition for Advancement of Medical Research (CAMR) and Americans for Cures Foundation. He also serves on the executive committee of the Alliance for Regenerative Medicine (ARM). He is a past co-chair of the Governmental Affairs Committee of the International Society for Stem Cell Research (ISSCR).
再生医学采访了遗传政策研究所（GPI）的执行主任兼年度世界干细胞峰会的创始人 Bernard Siegel。Bernard Siegel，法学博士，是总部位于美国佛罗里达州惠灵顿的非营利组织遗传政策研究所（GPI）的创始人兼全职执行董事。他是全球系列会议世界干细胞峰会的创建者和联合主席，也是世界干细胞报告的编辑，他也创立了该报告。他放弃了 30 年的法庭生涯，创立了 GPI，该组织领导着全球的“Pro-Cures 运动”和干细胞行动联盟。作为一名干细胞研究、再生医学和克隆领域的公认政策专家，Siegel 先生与世界领先的干细胞研究人员和倡导者合作。Siegel 先生是医学研究促进联盟（CAMR）和美国人治愈基金会董事会的成员。他还担任再生医学联盟（ARM）的执行委员会成员。他曾是国际干细胞研究学会（ISSCR）政府事务委员会的联合主席。
